Agios Pharmaceuticals Email Format

Pharmaceutical ManufacturingMassachusetts, United States501-1000 Employees

Agios Pharmaceuticals is a commercial-stage biopharmaceutical company in the pharmaceutical manufacturing industry, located at 88 Sidney Street, Cambridge, Massachusetts. The company focuses on rare diseases, particularly hematology, and collaborates with patient communities to develop and deliver medicines aligned with their priorities. It aims to advance a growing pipeline by combining deep biological expertise with real-world insights, supported by an inclusive, collaborative culture. Agios has pursued licensing and collaboration arrangements, including exclusive global rights to cevidoplenib, a novel oral spleen tyrosine kinase inhibitor, and a partnership with Oscotec, as well as a distribution agreement for PYRUKYND across the European Economic Area, the United Kingdom, and Switzerland. The company engages with regulatory processes and agencies as part of its development programs, including collaboration with the U.S. FDA on labeling and REMS materials.

Sign up for free to view info

Company overview Employee directory